维普期刊资源整合服务平台（V6.5）

76篇 您的检索式：作者名="Marzolini C"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Polymorphisms in human MDR (P-glycoprotein):recent advances and clinical relevance显示文摘	Marzolini C Paus E Buclin T	2004	Clin Phamacol Ther2004，75，1：	1
2	Polymorphisms in human MDR1 (P-glycoprotein):recent advances and clinical relevance显示文摘	Marzolini C Paus E Buclin T	2004	Clin Pharmacol Ther2004，75，1：	1
3	Polymophisma in human MDR1(P-glycoprotein):recent advances and clinical relevance显示文摘	Marzolini C Paus E Buclin T	2004	Clin Pharmacol Ther2004，75，1：	1
4	Polymorphisms in human MDRI (P-glycoprotein):recent advances and clinical relevance显示文摘	Marzolini C Paus E Buclin T	2004	Clin Pharmacol Ther2004，75，：	1
5	Polymorphisms in hunman MDR1 (P-glycoproteim) :recent advances and clinical relevance显示文摘	Marzolini C Paus E Bucin T	2004	Clin Pharmacol Ther2004，75，1：	1
6	Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction : application for the assessment of their transplacental passage at delivery显示文摘	Marzolini C Beguin A Telenti A	2002	J Chromatgr B2002，774，2：	1
7	Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV- l-infected patients 显示文摘	Marzolini C Telenti A Decosterd LA	2001	AIDS2001，15，1：	1
8	Polymorphisms in human Mdrl (P-Glycoprotein) : Recent Advances and Clinical Relevance 显示文摘	Marzolini C Pans E Buclin T	2004	Clin Parmacol Ther2004，75，1：	1
9	Polymorphisms in human MDR1(Pglycoprotein):recent advances and clinical relevance显示文摘	Marzolini C Paus E Buclin T	2004	Clin Pharmacol Ther2004，75，1：	1
10	Polymorphisms in human MDR 1 (P-glycoprotein):recent advances and clinical relevance显示文摘	Paus E Buclin T	2004	Clin Pharmacol Ther2004，75，1：	1
11	Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV infected patients显示文摘	Marzolini C Telenti A Decosterd LA	2001	AIDS2001，13，：	1
12	Response to antiretroviral treatment in HIV 1-infected individuals withalleic variants of the multidrug resistance transporter 1: a pharmacogenetics study 显示文摘	Marzolini C Meaden ER	2002	Lancet2002，359，：	1
13	Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV- 1-infectedpatients显示文摘	Marzolini C Telenti A Decosterd LA	2001	AIDS2001，15，：	1
14	A Common polymorphism in the bile acid receptor farnesoid x receptor is associated with decreased hepatic target gene expression 显示文摘	Marzolini C Tirona RG Gervasini G	2007	Endocrinol2007，21，8：	1
15	Polymorphisms in human MDR1 (P-glycoprotein):recent advances and clinical relevance显示文摘	Marzolini C Paus E Buclin T	2004	Clin Pharmacol Ther2004，75，1：	1
16	Phannacokinet- ics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial ad- ministration显示文摘	Marzolini C Decosterd LA Shen F	1998	Cancer Chemother Pharmacol1998，42，6：	1
17	Determination of the Novel Non-peptidic HIV-protease Inhibitor Tipranavir by HPLC-UV after Solid-phase Extraction显示文摘	COLOMBO S BEGUIN A MARZOLINI C	2006	J Chromatogr B Analyt Technol Biomed Life Sci2006，，1：	1
18	Polymorphsims in human MDRI (P-glycoprotein):recent advances and clinical relevance显示文摘	Marzolini C Paus E Buclin T	2004	Clin Pharmacol Ther2004，75，1：	1
19	Response to antiretroviral treatment in HIV-l-infected individuals with allelic variants of the multidrug resistance transporterl : a pharmacogenetics study 显示文摘	Fellay J Marzolini C Meaden ER	2002	Lancet2002，359，9300：	1
20	Polymorphisms in human MDR1 (P-glycoprotein) : recent advances andclinical relevance显示文摘	Marzolini C Paus E Buclin T	2004	Clin Pharmacol Ther2004，75，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示